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ABSTRACT 
 
Life expectancy gap between people with severe mental illness (SMI, schizophrenia, schizoaffective 
disorder and bipolar disorder) and general population remains. This study aims to estimate 
contributions of specific causes of death to the gap. 
 
All-cause death in the observation period was used to calculate the life expectancy at birth for people 
with SMI by gender. Hypothetical changes in life expectancy were then re-calculated after equalling 
each cause-specific death rate to that in the general population of England & Wales in 2010. 
 
Overall, natural causes (i.e. discounting suicide and other external causes) took 79.2% (female) and 
78.6% (male) lost life-years respectively. Deaths from circulatory disorders accounted for more life-
year lost in women than men (2.24 years, 22.0% of contributed person-years versus 1.82 years, 17.4% 
of person-years, respectively), as did deaths from cancer (8.1% versus no contribution). Less 
contribution was detected among females for respiratory disorders (13.7% versus 16.5%). Similar 
contributions were found for digestive disorders (9.9% versus 8.8%), suicide (13.6% versus 13.4%), 
and other external causes (7.2% versus 8.0%). 
 
Loss of life expectancy in people with SMI is accounted for by a broad range of causes of death with 
specific gender differences. Interventions focused on multiple rather than individual causes of death 
should be prioritised accordingly. 
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INTRODUCTION 
 
Premature death among people with mental disorders is an international concern [1]. Individuals with 
severe mental illness (SMI) with psychotic symptoms, including schizophrenia, schizoaffective 
disorder and bipolar disorder, experience particularly higher all-cause mortality and lower life 
expectancy [2,3]. This is an important indicator for policy development to improve on current health 
inequality; however, contributions of individual causes of death to the life expectancy gap remain 
unclear, seriously limiting the evidence. Previous research has suggested excesses of both natural and 
unnatural causes of death, and that the excess of natural causes may cross several mental disorder 
groups [4]. Nevertheless, standardised mortality ratios cannot be translated into the more important 
construct of life expectancy, because the latter indicator emphasising age pattern of death. Using data 
from a large clinical cohort, we estimated the contribution of the major groups of causes of death to 
shortened life expectancy in people with SMI, delineating to what extent this gap could conceivably 
be closed if mortality rates for each cause of death could be equalised with those in the general 
population. 
 
 
METHODS 
 
Data sources and cohort 
The South London and Maudsley NHS Foundation Trust (SLAM) is one of Europe’s largest 
secondary mental healthcare providers, serving a single geographic catchment of approximately 1.36 
million residents in four southeast London boroughs. In 2006, fully electronic health records were 
implemented across all SLAM services, and, in 2008, the Clinical Record Interactive Search (CRIS) 
system, supported by the National Institute of Health Research (NIHR) Biomedical Research Centre 
for Mental Health at SLAM, was developed to allow search and retrieval of anonymised but complete 
medical records within a robust patient-led governance framework [5,6]. Using CRIS, individuals 
who received a primary diagnosis of SMI (schizophrenia, ICD-10 coded F20; schizoaffective 
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disorder, F25, or bipolar affective disorder, F31) during the period between 1st Jan 2007 and 31st Dec 
2012 were included in this analysis. Recorded primary diagnoses in structured fields of the record 
were supplemented by a natural language processing application developed using Generalised 
Architecture for Text Engineering (GATE) software to identify diagnostic statements in open text 
fields (i.e. correspondence letters and clinical notes) [6,7]. 
 
Mortality 
Date and primary cause of death for our study subjects in the same period (2007-2012 inclusive) were 
retrieved from a CRIS linkage to death certifications, held by the UK Office of National Statistics 
which is updated regularly [8], by NHS numbers through an anonymised process. The same data 
source (i.e. UK Office of National Statistics), but this time via online data files, was used to obtain 
age-, gender, and cause-specific mortality for England & Wales population in 2010 [9]. Since an SMI 
diagnosis is unlikely to be given to subjects under the age of 15 years, we assumed equal mortality 
rates up to that point as to those in the general population of England & Wales in 2010. 
 
Baseline life expectancy at birth 
Using Microsoft Excel software, life expectancy at birth was estimated using Chiang’s abridged life-
table method [10]. In brief, the accumulated person-years were calculated by gender based on age- 
and gender-specific mortality experienced by a specified male / female cohort in five-year age bands, 
and then divided by the total number of male / female cohort subjects at baseline. Because of dynamic 
nature of our cohort during the six-year follow-up period (2007-2012), we weighted the number of 
deaths observed by the average at-risk period of each age and gender band. We also estimated the life 
expectancy at birth for the England & Wales population using 2010 data for the purpose of validation 
on Chiang’s abridged method [10,11]. 
 
Re-calculated life expectancies by equalising mortality rates 
A life expectancy simulation was used to examine the contribution of major causes of mortality to the 
elevated mortality in people with SMI. Death rates in SMI cohort for each major primary cause 
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category were sequentially replaced with England and Wales gender- and age-specific rates for that 
cause of death, obtained from UK Office of National Statistics [9]. The expected number of deaths in 
each five-year age band was then re-calculated using these national gender- and age-specific rates. 
These re-estimations were carried out for cause-of-death categories by the order of number of deaths 
observed in the SMI study cohort: i) circulatory diseases, ii) cancer, iii) respiratory diseases, iv) 
digestive diseases, v) suicide, vi) deaths due to other (non-suicide) external causes, and vii) all 
remaining causes of death. Where there was a reverse association identified for any cause-of-death 
category (i.e. a lower life expectancy for SMI subjects following equalisation of a specific cause-of-
death category to genera population), its contribution to loss of life expectancy was set zero. 
Percentage of person-year contribution to the gap for each category of death was then calculated 
accordingly. In sensitivity analysis, the adjustment for cancer was re-applied taking into account 
reference to cancer anywhere on the death certificate rather than the primary cause of death. 
 
 
RESULTS 
 
Calculating by Chiang’s method, the life expectancy at birth for the England and Wales population in 
2010 was 78.5 (95% CI 78.1-78.8) years for males and 82.4 (95% CI 82.1-82.7) years for females, 
which were identical to what reported by the UK ONS [11]. In the SLAM cohort, there were 1,558 
deaths during the observation period among 19,106 subjects with SMI (816 deaths among 10,414 
males and 742 deaths among 8,692 females). The life expectancy at birth in people with SMI was 
estimated to be 67.9 years (95% CI 67.1-68.6) for men and 72.2 years (95% CI 71.5-72.8) for women 
– i.e. reduced by 10.6 years for men and 10.2 years for women. Summarised in Table 1, the leading 
cause of death in those with SMI was circulatory diseases, followed by cancer, respiratory disease, 
gastrointestinal disorders, suicide, and other external causes. 
 
Figures 1 and 2 represent the incremental improvements to life expectancy by gender when major 
cause of death’s category was sequentially replaced with the England and Wales population rates in 
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2010 one by one. The incremental changes to hypothetical male life expectancy from the baseline 
67.9 years were: 69.7 years by equalising circulatory disease death rates to those in the general 
population, 69.7 years (i.e. no change) by further equalising cancer mortality, 71.4 years equalising 
respiratory disease, 72.3 years equalising gastrointestinal diseases, 73.6 years equalising suicide, 74.5 
years equalising all other external causes, and finally attaining the national level of 78.5 years by 
equalising all remaining causes. The corresponding changes to the life expectancy at birth for females 
from the baseline 72.2 years were: 74.4 years (circulatory diseases), 75.2 years (cancer), 76.6 years 
(respiratory diseases), 77.7 years (gastrointestinal diseases), 79.1 years (suicide), 79.8 years (other 
external causes), and 82.4 years (all remaining causes). These increments are visually displayed in 
Figures 1-2 and are expressed in terms of life years gained and as proportions of the life expectancy 
gap in Table 1. 
 
To further address the issue if position of cancer on death certificate varied between people with SMI 
and general population, another set of sensitivity analysis was carried out. This was done by 
equalising mortality rates where cancer was recorded anywhere on the death certificate and we found 
this did not change the findings substantially: resulting in a 0.06 year reduction of life expectancy 
among males with SMI and an improvement of life expectancy for females by 0.22 years when 
comparing rates from cancer as primary cause of death or as a contributory factor (details not shown). 
 
 
DISCUSSION 
 
With a large cohort of people with SMI, we investigated the contributions of causes of death 
underlying the reduced life expectancy, which has been well-recognised in this vulnerable group. Our 
aim was to estimate the improvements in life expectancy which might be achieved if people with SMI 
could experience the same age- and gender-specific mortality rates as the general population. The 
main finding was that the gap in life expectancy was accounted for by a wide range of underlying 
causes of death, rather than just one or two predominating ones. Meanwhile, some elements in the 
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pattern of contribution differed between men and women. The results drew an alternative picture of 
individuals with SMI having high mortality risk across all causes of death. 
 
When assessing the specific contribution from each cause of death to life expectancy on where the 
greatest impact and least impact by gender lies, it was difficult to identify a single group or two that 
affects a specific gender. As single groups of causes, circulatory and respiratory were highest in males 
and females, but when we grouped all causes other than circulatory, respiratory, cancer, digestive, 
external and suicide, the rest causes of death still contributed 35.9% for male and 25.5% for female to 
the gap, displaying its highly heterogenic nature. 
 
As stated, life expectancy is a more meaningful construct than standardised mortality for public 
health, as it takes into account not only the level of mortality but also age distributions. Disorders 
affecting mortality at younger age therefore have a higher impact on life expectancy, even if 
associated mortality rates are similar or even lower than those of later-life disorders. Estimated life 
expectancies at birth for male and female cohort members in our analysis were comparable to those 
previously reported from the CRIS database [3]. Both are substantially lower than the life expectancy 
at birth for men and women in the England & Wales population in 2010 (78.5 and 82.4 years, 
respectively). The importance of ‘natural’ causes (i.e. rather than suicide or violence) accounting for 
the mortality gap is increasingly recognised. For example, in a population of 292,585 people in 
contact with mental health services, 77.7% of excess deaths were found to be accounted for by 
physical conditions, of which cardiovascular illnesses contributed 29.9% and cancers contributed 
13.5%, compared to 13.9% of excess deaths caused by suicide [12]. In that study, excess mortality by 
cause was defined as the difference between the observed number of deaths (the total person-years in 
the cohort of psychiatric patients) and the expected number of deaths (expected numbers of deaths in 
the cohort by major cause of death using cause-specific death rates by age group, sex, and time 
period) [12]. Kessing et al (2015) also found that among men with SMI, 74% of life years lost after 
age 15 were due to natural causes and, among female counterparts, figure was 80% [13]. In our 
cohort, natural causes accounted for 78% and 77% respectively. Suicide clearly remains an important 
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adverse outcome in SMI with a 5% lifetime risk estimated for people with schizophrenia [14]. It 
accounted for approximate 1.4 life years lost for both genders (13.4% in men and 13.6% in women for 
its contribution) in our sample. 
 
Our findings revealed a minor effect of deaths from cancers, especially for male SMI subjects. Other 
studies have also shown increase in mortality due to cardiovascular diseases and infectious diseases, 
but, unlike in our study, their subjects also experienced increases to deaths of cancer with up to 1.4 to 
2.0 folds of increasing risks [15]. The explanation is simply that cancer deaths happen later than other 
causes, resulting in less impact on life expectancy among people with SMI. Our study remains unique 
for its methodology emphasising the impact of mortality pattern for each major death cause 
categories, rather than comparing summed risks for people with mental illness as the above studies. 
Our study provides an overview of all cancer deaths in the SMI population in the given time period, in 
response to our previous finding of similar patterns in presentation / diagnosis of cancer to that of 
general population [16]. 
 
Despite the well-recognised importance of deaths from natural causes in SMI, investigations and 
suggested interventions have tended to focus on specific causes of death such as cardiovascular 
disease, although comparable morbidity has been reported in other systems [17]. Our findings suggest 
that this is over-simplistic and that a range of recorded causes potentially underlie the gap in 
premature mortality. The widening mortality gap between people with and without SMI is primarily 
accounted for by progressively improving survival rates in the general population which are not being 
experienced by people with SMI, rather than by rising absolute mortality in SMI [4]. Furthermore, 
risk factors for mortality have high prevalence in people with SMI include smoking, alcohol, 
recreational drug use, poor diet and lack of exercise [18-22]. These are potentially implicated in a 
number of causes of death and their associations with mortality have been found to be stronger than 
expected in SMI [22]. General health promotion activities are therefore most likely to have an impact 
on life expectancy, including improvements in the availability and accessibility of prevention and risk 
management services, as well as addressing inequalities in treatment receipt where life-threatening 
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conditions are present [23]. It is also clearly important to consider side effects of some psychotropic 
medications, such as the weight gain and hyperlipidaemia which affect a high proportion of patients 
during initiation or maintenance of antipsychotic treatment [21]. Improving the availability and 
accessibility of prevention and risk management services could be an important means to minimise 
the mortality gap, but broader attention is also needed to address profound socio-economic 
inequalities. 
 
Although 13% of deaths for this cohort were due to cancer, the third leading cause of death, there was 
no improvement to life expectancy at birth among men when England and Wales cancer mortality 
rates were substituted. We considered the possibility that cancer was a potential underlying cause of 
death but not always considered or recorded as the primary cause in death certificates (e.g. because of 
deaths from respiratory disease in people with advanced cancer). However, there was minimal 
alteration in findings when mortality rates were substituted where cancer was recorded anywhere on 
the death certificate. Of all cancer mortality in women with SMI, the commonest cause in our sample 
was breast cancer (n=179) leading to a mean age at death of 67.7 years followed by lung cancer 
(n=110) with mean age at death of 71.7 years. For males, the commonest cancer causing death was 
lung cancer (n=128) with mean age at death of 70.9 years followed by prostate cancer (n=101) with 
mean age at death of 78.0 years. The younger age of deaths from breast cancer could therefore explain 
the greater impact on life expectancy among females. Our finding for cardiovascular disease 
accounting for a higher proportion of life expectancy in women was similar to those of another study 
findings with higher contributions from cardiovascular disease to excess deaths in female compared to 
male patients with mental disorders (35.2% and 26.2%, respectively) [12]. 
 
Strengths of our study include the large sample size and linkage to nationwide mortality, with up to 
six years of follow up. This study adds to the literature by showing contribution of each major cause 
of death to its current life expectancy compared to England and Wales which provides a full picture of 
difference in mortality compared to excess mortality alone. Generalisability of our analysis might 
need to be further considered, as the findings for life expectancy at birth clearly refer to people with 
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these mental disorders who had made contact with secondary mental health services within the 
specified time period. In this respect, the secondary healthcare setting is unlikely to bias findings to a 
large extent as SMIs by nature are disorders where most cases will have received secondary care 
input. The limitations of this study may come from its inclusion criteria as it included anyone with a 
SMI diagnosis whether or not they had other mental health diagnoses as well. This was done to ensure 
the study was most inclusive to patients experiencing psychotic symptoms and had a diagnosis of F20, 
F25 or F31 ICD-10 conditions. There is potential for introducing survivor bias with the individuals 
that survive the longest, the highest risk period potentially being after first diagnosis, being included. 
However, the aim of this study is to highlight the patterns of mortality as estimated by life expectancy. 
Although SLAM is a major academic as well as clinical centre, mental disorders defined from its 
records are likely to be broadly generalisable to other UK urban and suburban settings. An important 
consideration in drawing inferences from our findings concerns the assumptions. These presupposed 
independent processes did not take into account the potential for interaction among causes of death or 
competing risks of death (e.g. that equalising cancer mortality might have less impact than expected 
on life expectancy because of persisting cardiovascular diseases). The estimated contributions to the 
life expectancy gap therefore need to be viewed cautiously, although the principal finding of multiple 
contributions remains. 
 
We carried out this study to improve understanding of premature mortality which has been a long-
lasting problem among people with severe mental illness and described as “… at worst, a form of 
lethal discrimination” [24]. While we agree with the other opinion in this area that the time has come 
to shift efforts towards interventions to improve survival, we believe that the observational data 
remains deficient as an evidence base. In particular, our findings suggest that prioritised interventions 
should be those which demonstrably have an impact on multiple causes of death, as clearly addressing 
a single cause will only have a small effect on life expectancy. In addition to receiving optimum 
mental healthcare, it is thus imperative that individuals with severe mental illnesses should receive a 
package of care to help improve lifestyle, diet, and proper medication management. It is also 
important to bear in mind current thinking on achieving health improvements through reducing health 
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inequalities and minimising the impact of socio-economic status on health advantages [25]. Failure to 
appreciate these challenges may result in resources being used inefficiently as what is most beneficial 
might be to tackle the issue in a systematic way. 
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Figure 1. Changes in the estimated life expectancy of men with SMI following successive equalisation of primary causes of death with rates of 
England and Wales in 2010 (N = 10,414) 
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Figure 2. Changes in the estimated life expectancy of women with SMI following successive equalisation of primary causes of death with rates of 
England and Wales in 2010 (N = 8,692) 
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Table 1. Number of deaths by primary cause (ICD-10 categories) in people with SMI and the hypothetical change in life expectancy following 
equalisation of these to England and Wales cause-specific mortality rates in 2010 
Gender Primary cause of death 
Number of deaths during 
2007-2012 (% of all deaths) 
Life expectancy improvement in years by 
equalising causes of death with those in 
general population 
Percentage of contribution to the gap 
of person-years 
Males Circulatory (I00-I99) 195 (23.9) 1.82 17.4 
Cancer (C00-D48) 110 (13.5) -0.02* -- 
Respiratory (J00-J99) 132 (16.2) 1.73 16.5 
Digestive (K00-K93) 55 (6.7) 0.92 8.8 
Suicide (X60-
X84,Y10-Y34) 
55 (6.7) 1.40 13.4 
Other external (V01-
Y98) 
57 (7.0) 0.84 8.0 
All other causes 212 (26.0) 3.76 35.9 
Females  Circulatory (I00-I99) 205 (27.6) 2.24 22.0 
Cancer (C00-D48) 148 (19.9) 0.83 8.1 
Respiratory (J00-J99) 114 (15.4) 1.40 13.7 
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Digestive (K00-K93) 40 (5.4) 1.01 9.9 
Suicide (X60-
X84,Y10-Y34) 
33 (4.4) 1.39 13.6 
Other external (V01-
Y98) 
28 (3.8) 0.74 7.2 
All other causes 174 (23.4) 2.60 25.5 
* Replaced by zero in the consecutive calculations 
